Emblica officinalis medicinal plants: A new approach in traditional herbal medicine

Anuj Kumar; Amandeep Singh

doi:10.53730/ijhs.v6nS5.10136

Authors

Anuj Kumar
anujgupta31454@gmail.com
Research Scholar, Dev Bhoomi Institute of Pharmacy and Research, Dehradun (Uttarakhand), pin code-248007
Amandeep Singh Professor, Dev Bhoomi Institute of Pharmacy and Research, Dehradun, (Uttarakhand), pin code-248007

Keywords:

Amla, Emblica officinalis, Medicinal uses, Pharmacology, Phytochemistry

Abstract

The herbal medicine is in the great demand in the developed as well as developing countries for primary health care because of their large biological activities, higher safety margin and lesser cost. one of the common traditional herbal drugs is Emblica officinalis, commonly known as Amla, is a member of a small genus Emblica (Euphorbiaceae). The earlier study has demonstrated potent anti-microbial, adaptogenic, hepatoprotective, anti-tumour and anti-ulcerogenic activities in the fruits of Emblica officinalis. Leaf extracts have been shown to possess anti-inflammatory activity. vitamin C, tannins and flavonoids present in amla have very powerful antioxidant activity. Due to rich in vitamin C amla is successfully use in the treatment of human scurvy. The extracts from various parts of E. officinalis, especially fruit, contain numerous phytoconstituents viz. higher amount of polyphenols like gallic acid, ellagic acid, different tannins, minerals, vitamins, amino acids, fixed oils, and flavonoids like rutin and quercetin. The extract or plant is identified to be efficacious against diversified ailments like inflammation, cancer, osteoporosis, neurological disorders, hypertension together with lifestyle diseases, parasitic and other infectious disorders.

Downloads

Download data is not yet available.

References

S. Rawal, P. Singh, A. Gupta, and S. Mohanty, “Dietary intake of Curcuma longa and Emblica officinalis increases life span in Drosophila melanogaster,” Biomed Res. Int., vol. 2014, p. 910290, 2014.

P. Mishra, M. Verma, V. Mishra, S. Mishra, and G. K. Rai, “Studies on Development of Ready to Eat Amla (Emblica officinalis) Chutney and its Preservation by using Class One Preservatives,” Am. J. Food Technol., vol. 6, no. 3, pp. 244–252, 2011.

A. Ihantola-Vormisto, J. Summanen, H. Kankaanranta, H. Vuorela, Z. M. Asmawi, and E. Moilanen, “Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica,” Planta Med., vol. 63, no. 6, pp. 518–524, 1997.

J. B. Perianayagam et al., “Evaluation of Antidiarrheal Potential of Emblica officinalis,” Pharm. Biol., vol. 43, no. 4, pp. 373–377, 2005.

N. N. Barthakur and N. P. Arnold, “Chemical analysis of the emblic (Phyllanthus emblica L.) and its potential as a food source,” Sci. Hortic. (Amsterdam), vol. 47, no. 1–2, pp. 99–105, 1991.

Zhang L.-Z., Zhao W.-H., Guo Y.-J., Tu G.-Z., Lin S., and Xin L.-G., “Studies on chemical constituents in fruits of Tibetan medicine Phyllanthus emblica,” Zhongguo Zhong Yao Za Zhi, vol. 28, no. 10, pp. 940–943, 2003.

Y. J. Zhang, T. Abe, T. Tanaka, C. R. Yang, and I. Kouno, “Phyllanemblinins A-F, new ellagitannins from Phyllanthus emblica,” J. Nat. Prod., vol. 64, no. 12, pp. 1527–1532, 2001.

Y.-J. Zhang, T. Abe, T. Tanaka, C.-R. Yang, and I. Kouno, “Two new acylated flavanone glycosides from the leaves and branches of Phyllanthus emblica,” Chem. Pharm. Bull. (Tokyo), vol. 50, no. 6, pp. 841–843, 2002.

Y.-J. Zhang, T. Tanaka, C.-R. Yang, and I. Kouno, “ChemInform abstract: New phenolic constituents from the fruit juice of Phyllanthus emblica,” ChemInform, vol. 32, no. 46, p. no-no, 2010.

Y. J. Zhang, T. Tanaka, Y. Iwamoto, C. R. Yang, and I. Kouno, “Novel norsesquiterpenoids from the roots of Phyllanthus emblica,” J. Nat. Prod., vol. 63, no. 11, pp. 1507–1510, 2000.

Y.-J. Zhang, T. Tanaka, Y. Iwamoto, C.-R. Yang, and I. Kouno, “Phyllaemblic acid, a novel highly oxygenated norbisabolane from the roots of Phyllanthus emblica,” Tetrahedron Lett., vol. 41, no. 11, pp. 1781–1784, 2000.

S. S. Subramanian, S. Nagarajan, and N. Sulochana, “Flavonoids of some euphorbiaceous plants,” Phytochemistry, vol. 10, no. 10, pp. 2548–2549, 1971.

S. K. Jain and D. S. Khurdiya, “Vitamin C enrichment of fruit juice based ready-to-serve beverages through blending of Indian gooseberry (Emblica officinalis Gaertn.) juice,” Plant Foods Hum. Nutr., vol. 59, no. 2, pp. 63–66, Spring 2004.

K. Tarwadi and V. Agte, “Antioxidant and micronutrient potential of common fruits available in the Indian subcontinent,” Int. J. Food Sci. Nutr., vol. 58, no. 5, pp. 341–349, 2007.

V. Bansal, A. Sharma, C. Ghanshyam, and M. L. Singla, “Coupling of chromatographic analyses with pretreatment for the determination of bioactive compounds in Emblica officinalis juice,” Anal. Methods, vol. 6, no. 2, pp. 410–418, 2014.

W.-Y. Qi, Y. Li, L. Hua, K. Wang, and K. Gao, “Cytotoxicity and structure activity relationships of phytosterol from Phyllanthus emblica,” Fitoterapia, vol. 84, pp. 252–256, 2013.

S. S. Nambiar, M. Paramesha, and N. P. Shetty, “Comparative analysis of phytochemical profile, antioxidant activities and foam prevention abilities of whole fruit, pulp and seeds of Emblica officinalis,” J. Food Sci. Technol., vol. 52, no. 11, pp. 7254–7262, 2015.

R. K. Goyal and S. S. Patel, “Emblica officinalis Geart.: A Comprehensive Review on Phytochemistry, Pharmacology and Ethnomedicinal Uses,” Res. J. Med. Plant, vol. 6, no. 1, pp. 6–16, 2012.

L. D. Kapoor, “Ayurvedic Medicinal Plants,” in CRC Handbook of Ayurvedic Medicinal Plants, CRC Press, 2018, pp. 5–346.

A. Bhattacharya, A. Chatterjee, S. Ghosal, and S. K. Bhattacharya, “Antioxidant activity of active tannoid principles of Emblica officinalis (amla),” Indian J. Exp. Biol., vol. 37, no. 7, pp. 676–680, 1999.

P. Scartezzini, F. Antognoni, M. A. Raggi, F. Poli, and C. Sabbioni, “Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic preparation of Emblica officinalis Gaertn,” J. Ethnopharmacol., vol. 104, no. 1–2, pp. 113–118, 2006.

O. N. Pozharitskaya, S. A. Ivanova, A. N. Shikov, and V. G. Makarov, “Separation and evaluation of free radical-scavenging activity of phenol components of Emblica officinalis extract by using an HPTLC-DPPH* method,” J. Sep. Sci., vol. 30, no. 9, pp. 1250–1254, 2007.

S. Bai, P. Bharti, L. Seasotiya, A. Malik, and S. Dalal, “In vitro screening and evaluation of some Indian medicinal plants for their potential to inhibit Jack bean and bacterial ureases causing urinary infections,” Pharm. Biol., vol. 53, no. 3, pp. 326–333, 2015.

V. D. Reddy, P. Padmavathi, M. Paramahamsa, and N. C. Varadacharyulu, “Amelioration of alcohol-induced oxidative stress by Emblica officinalis (amla) in rats,” Indian J. Biochem. Biophys., vol. 47, no. 1, pp. 20–25, 2010.

G. Andican et al., “Oxidative stress and nitric oxide in rats with alcohol-induced acute pancreatitis,” World J. Gastroenterol., vol. 11, no. 15, pp. 2340–2345, 2005.

M. M. Shivananjappa and M. K. Joshi, “Influence of Emblica officinalis aqueous extract on growth and antioxidant defense system of human hepatoma cell line (HepG2),” Pharm. Biol., vol. 50, no. 4, pp. 497–505, 2012.

Y. Zhang et al., “Chemical constituents from Phyllanthus emblica and the cytoprotective effects on H2O2-induced PC12 cell injuries,” Arch. Pharm. Res., vol. 39, no. 9, pp. 1202–1211, 2016.

K. Platel and K. Srinivasan, “Plant foods in the management of diabetes mellitus: vegetables as potential hypoglycaemic agents,” Nahrung, vol. 41, no. 2, pp. 68–74, 1997.

K. Srinivasan, “Plant foods in the management of diabetes mellitus: spices as beneficial antidiabetic food adjuncts,” Int. J. Food Sci. Nutr., vol. 56, no. 6, pp. 399–414, 2005.

J. K. Grover, S. Yadav, and V. Vats, “Medicinal plants of India with anti-diabetic potential,” J. Ethnopharmacol., vol. 81, no. 1, pp. 81–100, 2002.

M. S. Akhtar, A. Ramzan, A. Ali, and M. Ahmad, “Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients,” Int. J. Food Sci. Nutr., vol. 62, no. 6, pp. 609–616, 2011.

T.-S. Chen et al., “Efficacy of epigallocatechin-3-gallate and Amla (Emblica officinalis) extract for the treatment of diabetic-uremic patients,” J. Med. Food, vol. 14, no. 7–8, pp. 718–723, 2011.

P. Nain, V. Saini, S. Sharma, and J. Nain, “Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats,” J. Ethnopharmacol., vol. 142, no. 1, pp. 65–71, 2012.

J. J. D’souza, P. P. D’souza, F. Fazal, A. Kumar, H. P. Bhat, and M. S. Baliga, “Anti-diabetic effects of the Indian indigenous fruit Emblica officinalis Gaertn: active constituents and modes of action,” Food Funct., vol. 5, no. 4, pp. 635–644, 2014.

L. Anila and N. R. Vijayalakshmi, “Beneficial effects of flavonoids from Sesamum indicum, Emblica officinalis and Momordica charantia,” Phytother. Res., vol. 14, no. 8, pp. 592–595, 2000.

V. Kasabri, “Emblica officinalis stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation in vitro,” European J. Med. Plants, vol. 4, no. 6, pp. 753–770, 2014.

N. A. Calcutt, “Potential mechanisms of neuropathic pain in diabetes,” Int. Rev. Neurobiol., vol. 50, pp. 205–228, 2002.

N. P. Kumar, A. R. Annamalai, and R. S. Thakur, “Antinociceptive property of Emblica officinalis Gaertn (Amla) in high fat diet-fed/low dose streptozotocin induced diabetic neuropathy in rats,” Indian J. Exp. Biol., vol. 47, no. 9, pp. 737–742, 2009.

Pankaj, “Anti-cancer cyclodextrin nanocapsules based formulation development for lung chemotherapy,” J. Pharm. Res. Int., pp. 54–63, 2021.

Mediastari, A. A. P. A. (2020). Local wisdom traditional medicine for the health and beauty of postpartum mother in Denpasar City, Bali Province, Indonesia. International Journal of Health & Medical Sciences, 3(1), 65-71. https://doi.org/10.31295/ijhms.v3n1.149

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864

P. Bhatt, S. Singh, S. Kumar Sharma, and S. Rabiu, “Development and characterization of fast dissolving buccal strip of frovatriptan succinate monoydrate for buccal delivery,” Int. J. Pharm. Investig., vol. 11, no. 1, pp. 69–75, 2021.